Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells

Amino Acids

Volumn 38, Issue 1, 2010, Pages 257-262

  Gismondi, Angelo ^a   Lentini, Alessandro ^a   Tabolacci, Claudio ^a   Provenzano, Bruno ^a   Beninati, Simone ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Differentiation; Melanin; Nimesulide; Polyamines; Transglutaminase; Tyrosinase

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; NIMESULIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SPERMIDINE; SPERMINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MELANOGENESIS; MELANOMA CELL; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; MELANINS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; POLYAMINES; SULFONAMIDES; TRANSGLUTAMINASES;

MURINAE;

EID: 76449118524     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0244-9     Document Type: Article

References (46)

1. AF Badawi 2000 The role of prostaglandin synthesis in prostate cancer BJU Int 85 451 462 10.1046/j.1464-410x.2000.00507.x 1:CAS:528:DC%2BD3cXisVens78%3D 10691825 (Pubitemid 30142622)
2. S Beninati 1995 Post-translational modification of protein in cancer cells: the transglutaminase catalysed reactions Cancer J 8 234 236
3. S Beninati JE Folk 1988 Covalent polyamine-protein conjugates: analysis and distribution Adv Exp Med Biol 250 411 422 1:CAS:528:DyaK3cXlvVykurs%3D 3076333
4. S Beninati M Piacentini 2004 The transglutaminase family: an overview Amino Acids 26 367 372 1:CAS:528:DC%2BD2cXmtVWktbw%3D 15290342
5. S Beninati A Abbruzzese M Cardinali 1993 Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells Int J Cancer 53 792 797 10.1002/ijc.2910530515 1:CAS:528:DyaK3sXltFCmsr4%3D 8095490
6. A Bennett G Villa 2000 Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities Expert Opin Pharmacother 1 2 277 286 10.1517/14656566.1.2.277 1:CAS:528: DC%2BD3cXntFSrtg%3D%3D 11249549
7. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
8. TH Chang E Szabo 2000 Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non small cell lung cancer Cancer Res 60 1129 1138 1:CAS:528:DC%2BD3cXhs1Shsbk%3D 10706135
9. SI Chung JE Folk 1972 Transglutaminase from hair follicle of guinea pig Proc Natl Acad Sci (Wash) 69 303 307 10.1073/pnas.69.2.303 1:CAS:528: DyaE38Xps1WhtQ%3D%3D
10. AJ Dannenberg NK Altorki JO Boyle C Dang LR Howe BB Weksler K Subbaramaiah 2001 Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol 2 9 544 551 10.1016/S1470-2045(01)00488-0 1:CAS:528:DC%2BD3MXntFCnu7o%3D 11905709 (Pubitemid 33586867)
11. A Denda W Kitayama A Murata H Kishida Y Sasaki O Kusuoka T Tsujiuchi M Tsutusumi D Nakae H Takagi Y Konishi 2002 Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide Carcinogenesis (Lond) 23 245 256 10.1093/carcin/23.2.245 1:CAS:528:DC%2BD38XitVGltLg%3D
12. Di Giacomo G, Lentini A, Beninati S, Piacentini M, Rodolfo C (2009) In vivo valuation of type 2 transglutaminase contribution to the metastasis formation in melanoma. Amino Acids (in press)
13. BG Erwin DZ Ewton JR Florini AE Pegg 1983 Polyamine depletion inhibits the differentiation of L6 myoblast cells Biochem Biophys Res Commun 114 3 944 949 10.1016/0006-291X(83)90651-4 1:CAS:528:DyaL3sXltVaqsb4%3D 6412710
14. JP Famaey 1997 In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview Inflamm Res 46 437 446 10.1007/s000110050221 1:CAS:528:DyaK2sXnsFGjtL0%3D 9427063 (Pubitemid 27507604)
15. IJ Fidler 1973 Selection of successive tumor cell lines for metastasis Nature (New Biol) 245 148 149 10.1038/245148a0
16. JE Folk 1980 Transglutaminases Ann Rev Biochem 49 517 531 10.1146/annurev.bi.49.070180.002505 1:CAS:528:DyaL3cXks1ChtLw%3D 6105840
17. M Fukutake S Nakatsugi T Isoi M Takahashi T Ohta S Mamiya Y Taniguchi H Sato K Fukuda T Sugimura K Wakabayashi 1998 Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2 on azoxymethane-induced colon carcinogenesis in mice Carcinogenesis (Lond) 19 1939 1942 10.1093/carcin/19.11. 1939 1:CAS:528:DyaK1cXnvVCnu74%3D
18. CS Greenberg PJ Birckbichler RH Rice 1991 Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues FASEB J 5 15 3071 3077 1:CAS:528:DyaK38XnvV2hsQ%3D%3D 1683845
19. RC Haydon L Zhou T Feng B Breyer H Cheng W Jiang A Ishikawa T Peabody A Montag MA Simon TC He 2002 Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma Clin Cancer Res 8 1288 1294 1:CAS:528:DC%2BD38XksVWjs7s%3D 12006550
20. AH Haynes MS Shaik A Chatterjee M Singh 2003 Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small cell lung cancer cell line Pharm Res 20 9 1485 1495 10.1023/A:1025774630993 1:CAS:528:DC%2BD3sXnt1KiurY%3D 14567645 (Pubitemid 37164058)
21. VJ Hearing K Tsukamoto 1991 Enzymatic control of pigmentation in mammals FASEB J 5 14 2902 2909 1:CAS:528:DyaK38XktVKl 1752358
22. O Heby 1981 Role of polyamines in the control of cell proliferation and differentiation Differentiation 19 1 20 10.1111/j.1432-0436.1981.tb01123.x 1:CAS:528:DyaL3MXktlOht7w%3D 6173280 (Pubitemid 11091193)
23. A Lentini S Beninati 2002 Differentiation therapy of cancer: transglutaminase as differentiative tool Minerva Biotech 14 159 164
24. A Lentini C Forni B Provenzano S Beninati 2007 Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential Amino Acids 32 1 95 100 10.1007/s00726-006-0304-3 1:CAS:528:DC%2BD28Xht1Ogs7rO 16699821 (Pubitemid 44866573)
25. Lentini A, Provenzano B, Tabolacci C, Beninati S (2009) Protein-polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids (in press)
26. R Lotan D Lotan 1980 Stimulation of melanogenesis in a human melanoma cell by retinoids Cancer Res 40 3345 3350 1:CAS:528:DyaL3cXlsl2ns7w%3D 6253061
27. JAM Maier T Hla T Maciag 1990 Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells J Biol Chem 265 19 10805 10808 1:CAS:528:DyaK3cXkslKgs7w%3D 1694171
28. LJ Marnett 1990 Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates Env Health Perspect 88 5 12 10.2307/3431044 1:CAS:528:DyaK3MXls12rsg%3D%3D
29. JL Masferrer KM Leahy AT Koki BS Zweifel SL Settle BM Woerner DA Edwards AG Flickinger RJ Moore K Seibert 2000 Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 1306 1311 1:CAS:528: DC%2BD3cXhvFWrt74%3D 10728691
30. MA Molina M Sitja-Arnau MG Lemoine ML Frazier FA Sinicrope 1999 Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 4356 4362 1:CAS:528:DyaK1MXlvVSmsLw%3D 10485483
31. E Mueller P Sarraf P Tontonoz RM Evans KJ Martin M Zhang C Fletcher S Singer BM Spiegelman 1998 Terminal differentiation of human breast cancer through PPARγ Mol Cell 1 465 470 10.1016/S1097-2765(00)80047-7 1:CAS:528:DyaK1cXhtlyhurk%3D 9660931
32. ML Parrett RE Harris FS Joarder MS Ross KP Clausen FM Robertson 1997 Cyclooxygenase-2 expression in human breast cancer Int J Oncol 10 503 507 1:CAS:528:DyaK2sXitVeisLk%3D
33. DH Russell 1977 Clinical relevance of polyamines as biochemical markers of tumor kinetics Clin Chem 23 1 22 27 1:CAS:528:DyaE2sXmvFCnsg%3D%3D 318939
34. FH Sarkar L Yiwei 2006 Using chemopreventive agents to enhance the efficacy of cancer therapy Cancer Res 66 7 3347 3350 10.1158/0008-5472.CAN-05- 4526 1:CAS:528:DC%2BD28XjtVOksbk%3D 16585150
35. P Sarraf E Mueller D Jones FJ King DJ De Angelo BJ Partridge SA Holden LB Chen S Singer C Fletcher MB Spiegelman 1998 Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat Med 4 9 1046 1052 10.1038/2030 1:CAS:528:DyaK1cXlvFGju7c%3D 9734398 (Pubitemid 28417337)
36. H Sheng J Shao S Kirkland P Isakson JR Coffey J Morrow RD Beauchamp RN DuBois 1997 Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 J Clin Invest 99 9 2254 2259 10.1172/JCI119400 1:CAS:528:DyaK2sXjtFCitrc%3D 9151799
37. K Subbaramaiah AJ Dannenberg 2003 Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol Sci 24 96 102 10.1016/S0165-6147(02)00043-3 1:CAS:528:DC%2BD3sXmt1aktA%3D%3D 12559775 (Pubitemid 36135884)
38. CW Tabor H Tabor 1985 Polyamines in microorganisms Microbiol Rev 49 1 81 99 1:CAS:528:DyaL2MXhvVWqur8%3D 3157043
39. CJ Thiele S Gore S Collins S Waxman W Miller 2000 Differentiate or die: tie view from Montreal Cell Death Differ 7 1014 1017 10.1038/sj.cdd.4400723 1:STN:280:DC%2BD3M7ovVGmtw%3D%3D 11279548
40. OC Trifan WF Durham VS Salazar J Horton BD Levine BS Zweifel TW Davis LJ Masferrer 2002 Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhoea side effect of CPT-11 Cancer Res 62 5778 5784 1:CAS:528:DC%2BD38XotFyktrs%3D 12384538
41. ON Tucker AJ Dannenberg EK Yang F Zhang L Teng JM Daly RA Soslow JL Masferrer MB Woerner TA Koki JT Fahey 1999 Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Res 59 987 990 1:CAS:528:DyaK1MXhslemtLw%3D 10070951
42. H Vosper GA Khoudoli CNA Palmer 2003 The peroxisome proliferator activated receptor δ is required for the differentiation of THP-1 monocytic cells by phorbol ester Nucl Recept 1 1 10 10.1186/1478-1336-1-9 (Pubitemid 39130371)
43. M Wick G Hurteau C Dessev C Daniel MW Geraci RA Winn LE Heasley RA Nemenoff 2002 Peroxisome proliferator-activated receptor-γ is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth Mol Pharm 62 1207 1214 10.1124/mol.62.5.1207 1:CAS:528:DC%2BD38XosVKisrk%3D (Pubitemid 35222513)
44. T Yokozawa YJ Kim 2007 Piceatannol inhibits melanogenesis by its antioxidative actions Biol. Pharm. Bull 30 11 2007 2011 10.1248/bpb.30.2007 1:CAS:528:DC%2BD1cXisVCnug%3D%3D 17978467 (Pubitemid 350103368)
45. KC Zimmermann M Sarbia AA Weber F Borchard HE Gabert K Schror 1999 Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Res 59 198 204 1:CAS:528:DyaK1MXms1ejsg%3D%3D 9892207
46. 2 in human head and neck xenograft tumors Cancer Res 62 6706 6711